The prices of sale and purchase of agricultural land in May 2024 significantly increased compared to the previous months and are now the highest for the entire existence of the land market: the weighted average price per hectare in May was 45.0 thousand UAH, which is 8.2% higher than in April 2024, and 5.6% higher than in March this year, according to a study by the Kyiv School of Economics (KSE), which is conducted on behalf of the USAID program.
According to analysts, the price of land with the intended purpose “for commercial agricultural production” was even higher and reached UAH 46.2 thousand.
“The above prices are based on the official prices registered in the Register of Property Rights during sale and purchase transactions. Market prices for land can be much higher, because most of all transactions are concluded at a price that does not differ from the normative-monetary valuation (the minimum price established by law for former sub-moratorial lands) by more than 2%,” the KSE clarified.
At the same time, experts believe that a slight decrease in prices in April 2024 and an increase in the cost of agricultural land in May this year is unlikely to be a long-term trend.
Since the beginning of 2024, average land prices remain significantly higher than in previous periods. Consequently, it can be stated that the opening of the land market for legal entities in January 2024 has led to structural changes in the market conditions, and as a consequence has led to an increase in the value of agricultural land, according to the KSE study “Land of Indestructibility”.
Farmak pharmaceutical company, within the framework of a strategic partnership with the Kyiv School of Economics (KSE), will allocate $ 500,000 for the development of KSE.
According to a press release from the pharmaceutical company, in particular, the funds will be used to equip a new campus, as well as to strengthen existing and launch new educational areas, including training bachelors.
“By supporting such projects, we are contributing to the achievement of the Global Sustainable Development Goals, one of the tasks of which is to improve the quality of higher education and ensure its close connection with science,” Executive Director of Farmak Volodymyr Kostiuk said.
The press release notes that Farmak supports not only KSE, but also other educational initiatives, including the Minor Academy of Sciences, publishes books about Ukrainian scientists. The company’s own scientific potential (150 scientists, 42 candidates of sciences, five doctors of sciences and an innovative R&D complex) allows providing a high level of academic expertise.
“The decision of Farmak company testifies that Ukrainian business is entering a new level of corporate social responsibility, and this should become an example for others. Thanks to the support of companies such as Farmak, we are preparing the ground for a strong and innovative Ukrainian economy,” President of KSE Tymofiy Mylovanov said.
Farmak is the leader of the Ukrainian pharmaceutical market, produces medicines in all 14 therapeutic groups. Annually it introduces to the market about 20 new complex component modern drugs. Currently, there are about 100 drugs in development. It exports products to more than 25 countries around the world.
Farmak pharmaceutical company, within the framework of a strategic partnership with the Kyiv School of Economics (KSE), will allocate $ 500,000 for the development of KSE.
According to a press release from the pharmaceutical company, in particular, the funds will be used to equip a new campus, as well as to strengthen existing and launch new educational areas, including training bachelors.
“By supporting such projects, we are contributing to the achievement of the Global Sustainable Development Goals, one of the tasks of which is to improve the quality of higher education and ensure its close connection with science,” Executive Director of Farmak Volodymyr Kostiuk said.
The press release notes that Farmak supports not only KSE, but also other educational initiatives, including the Minor Academy of Sciences, publishes books about Ukrainian scientists. The company’s own scientific potential (150 scientists, 42 candidates of sciences, five doctors of sciences and an innovative R&D complex) allows providing a high level of academic expertise.
“The decision of Farmak company testifies that Ukrainian business is entering a new level of corporate social responsibility, and this should become an example for others. Thanks to the support of companies such as Farmak, we are preparing the ground for a strong and innovative Ukrainian economy,” President of KSE Tymofiy Mylovanov said.
Farmak is the leader of the Ukrainian pharmaceutical market, produces medicines in all 14 therapeutic groups. Annually it introduces to the market about 20 new complex component modern drugs. Currently, there are about 100 drugs in development. It exports products to more than 25 countries around the world.
